Farewell to Chris Richardson

Chris Richardson joined the lab as a Postdoctoral Fellow in July 2014 and made huge advances in human gene editing. He developed new ways to improve NHEJ and HDR, plus discovered out that genome editing in human cells works via the Fanconi Anemia Pathway. Three major first author papers in three years – not bad! Chris will be joining Spotlight Therapeutics as a Group Leader, and may have some additional career news to share soon. We wish you success in all your future endeavors!

SUBMIT A COMMENT

Your email address will not be published. Required fields are marked *

Filters

Latest News

May 15, 2023

Welcome to Nicola

Nicola received his B.Sc in Biology from ETH Zürich in 2021. He is currently enrolled in the Molecular Health Sciences Master´s degree at ETH Zürich and joined...

April 21, 2023

Welcome to Naomi!

Naomi received her Bachelor’s degree in Health Science and Technology from ETH Zurich in 2021. Naomi joined the Corn lab in March 2023 as a Master student. For...

March 7, 2023

Congratulations to Mandy on the Innosuisse grant!

Mandy was awarded the Innosuisse Innovation grant to fund her translational work on developing gene therapies for hereditary blood diseases. This grant ...

News Archive

Tweets